Cancer Genetics (CGIX) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Cancer Genetics (CGIX) Misses Q4 EPS by 2c

Cancer Genetics, Inc. Announces Strong Fourth Quarter and Full-Year 2015 Results and Provides 2016 Business Update

March 10, 2016 3:53 PM EST

Full-Year 2015 revenues up 77% year-over-year to $18 MillionFourth Quarter revenues up 36% year-over-year to $5.5 MillionClosed 2015 with strong cash balance of $19.5 MillionConference call begins at 5:00 p.m. Eastern time today

RUTHERFORD, N.J., March 10, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in enabling precision medicine for oncology diagnostics, announced financial and operating results for the fourth quarter and full-year-ended December 31, 2015 and provided an update on the business progress for 2016.

Our business continues to scale as we integrate the acquisition of Response Genetics, focus on expanding our biopharma... More